Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma

British Journal of Cancer

Volumn 110, Issue 6, 2014, Pages 1446-1455

  Lauttia, S ^a   Sihto, H ^a   Kavola, H ^b   Koljonen, V ^b   Bohling T ^b,c   Joensuu, H ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Merkel cell carcinoma; Merkel cell polyomavirus; prokineticin; survival; tumour infiltrating leukocyte

Indexed keywords

CD163 ANTIGEN; CD68 ANTIGEN; CHEMOKINE; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; MESSENGER RNA; PROKINETICIN 2; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER CELL; CELL INFILTRATION; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MERKEL CELL POLYOMAVIRUS INFECTION; MERKEL CELL TUMOR; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SURVIVAL RATE;

ADULT; CARCINOMA, MERKEL CELL; FEMALE; GASTROINTESTINAL HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPEPTIDES; POLYOMAVIRUS INFECTIONS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 84896492425     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.20     Document Type: Article

References (45)

1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363: 24-35.
2. Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW (2010) Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome. Int J Cancer 127: 1493-1496.
3. Ciudad C, Aviles JA, Alfageme F, Lecona M, Suarez R, Lazaro P (2010) Spontaneous regression in merkel cell carcinoma: report of two cases with a description of dermoscopic features and review of the literature. Dermatol Surg 36: 687-693.
4. Curtis VF, Wang H, Yang P, McLendon RE, Li X, Zhou QY, Wang XF (2013) A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer. PLoS One 8: e54916.
5. Denison FC, Battersby S, King AE, Szuber M, Jabbour HN (2008) Prokineticin-1: a novel mediator of the inflammatory response in third-trimester human placenta. Endocrinology 149: 3470-3477.
6. Dorsch M, Qiu Y, Soler D, Frank N, Duong T, Goodearl A, O'Neil S, Lora J, Fraser CC (2005) PK1/EG-VEGF induces monocyte differentiation and activation. J Leukoc Biol 78: 426-434.
7. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW (2002) Merkel cell carcinoma and HIV infection. Lancet 359: 497-498.
8. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319: 1096-1100.
9. Giannini E, Lattanzi R, Nicotra A, Campese AF, Grazioli P, Screpanti I, Balboni G, Salvadori S, Sacerdote P, Negri L (2009) The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci USA 106: 14646-14651.
10. Houben R, Schrama D, Becker JC (2009) Molecular pathogenesis of Merkel cell carcinoma. Exp Dermatol 18: 193-198.
11. Kohler S, Kerl H (2006) Merkel cell carcinoma. In: Pathology and Genetics of Skin Tumours. World Health Organization Classification of Tumours, LeBoit P, Burg G, Weedon D, Sarasin A (eds) pp 272-273. IARC Press: Lyon, France.
12. Lanoy E, Costagliola D, Engels EA (2010) Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults. Int J Cancer 126: 1724-1731.
13. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412: 877-884.
14. LeCouter J, Lin R, Tejada M, Frantz G, Peale F, Hillan KJ, Ferrara N (2003) The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells. Proc Natl Acad Sci USA 100: 2685-2690.
15. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N (2004) Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 101: 16813-16818.
16. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, Johnson TM, Liegeois-Kwon NJ, Otley CC, Paulson KG, Ross MI, Yu SS, Zeitouni NC, Byrd DR, Sondak VK, Gershenwald JE, Sober AJ, Nghiem P (2010) Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 63: 751-761.
17. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY (2001) Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 59: 692-698.
18. Li QF, Zhu HY, Yang YF, Liu J, Xiao FJ, Zhang QW, Wu CT, Wang H, Wang LS (2010) Prokineticin-1/endocrine gland-derived vascular endothelial growth factor is a survival factor for human multiple myeloma cells. Leuk Lymphoma 51: 1902-1912.
19. Martucci C, Franchi S, Giannini E, Tian H, Melchiorri P, Negri L, Sacerdote P (2006) Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol 147: 225-234.
20. Monnier J, Piquet-Pellorce C, Feige JJ, Musso O, Clement B, Turlin B, Theret N, Samson M (2008) Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma. World J Gastroenterol 14: 1182-1191.
21. Monnier J, Samson M (2008) Cytokine properties of prokineticins. FEBS J 275: 4014-4021.
22. Monnier J, Samson M (2010) Prokineticins in angiogenesis and cancer. Cancer Lett 296: 144-149.
23. Morales A, Vilchis F, Chavez B, Chan C, Robles-Diaz G, Diaz-Sanchez V (2007) Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. J Steroid Biochem Mol Biol 107: 37-41.
24. Nagano H, Goi T, Koneri K, Hirono Y, Katayama K, Yamaguchi A (2007) Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer. J Surg Oncol 96: 605-610.
25. Ngan ES, Lee KY, Yeung WS, Ngan HY, Ng EH, Ho PC (2006) Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma. Endocrinology 147: 88-95.
26. Ngan ES, Sit FY, Lee K, Miao X, Yuan Z, Wang W, Nicholls JM, Wong KK, Garcia-Barcelo M, Lui VC, Tam PK (2007) Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin Cancer Res 13: 868-875.
27. Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V, Mascolo M, Tramontano D, Bellastella A, Sinisi AA (2006) The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/ prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology 147: 4245-4251.
28. Pasquali D, Santoro A, Bufo P, Conzo G, Deery WJ, Renzullo A, Accardo G, Sacco V, Bellastella A, Pannone G (2011) Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation. Thyroid 21: 391-399.
29. Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR, Koelle DM, Galloway DA, Leonard JH, Madeleine MM, Argenyi ZB, Disis ML, Becker JC, Cleary MA, Nghiem P (2011) Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8 + lymphocyte invasion as an independent predictor of survival. J Clin Oncol 29: 1539-1546.
30. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313: 856-862.
31. Richetta AG, Mancini M, Torroni A, Lore B, Iannetti G, Sardella B, Calvieri S (2008) Total spontaneous regression of advanced Merkel cell carcinoma after biopsy: review and a new case. Dermatol Surg 34: 815-822.
32. Shojaei F, Singh M, Thompson JD, Ferrara N (2008) Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proc Natl Acad Sci USA 105: 2640-2645.
33. Shojaei F, Wu X, Zhong C, Yu L, Liang XH, Yao J, Blanchard D, Bais C, Peale FV, van Bruggen N, Ho C, Ross J, Tan M, Carano RA, Meng YG, Ferrara N (2007) Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 450: 825-831.
34. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore PS, Chang Y (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci USA 105: 16272-16277.
35. Sihto H, Bohling T, Kavola H, Koljonen V, Salmi M, Jalkanen S, Joensuu H (2012) Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study. Clin Cancer Res 18: 2872-2881.
36. Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2009a) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101: 938-945.
37. Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma. Clin Cancer Res 17: 4806-4813.
38. Sihto H, Tynninen O, Halonen M, Puputti M, Karjalainen-Lindsberg ML, Kukko H, Joensuu H (2009b) Tumour microvessel endothelial cell KIT and stem cell factor expression in human solid tumours. Histopathology 55: 544-553.
39. Tadmor T, Aviv A, Polliack A (2011) Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Ann Oncol 22: 250-256.
40. Teppo L, Pukkala E, Saxen E (1985) Multiple cancer-an epidemiologic exercise in Finland. J Natl Cancer Inst 75: 207-217.
41. Waltari M, Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H (2011) Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma. Int J Cancer 129: 619-628.
42. Watson RP, Lilley E, Panesar M, Bhalay G, Langridge S, Tian SS, McClenaghan C, Ropenga A, Zeng F, Nash MS (2012) Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport. Neurogastroenterol Motil 24: 65-75, e12.
43. Wooff JC, Trites JR, Walsh NM, Bullock MJ (2010) Complete spontaneous regression of metastatic merkel cell carcinoma: a case report and review of the literature. Am J Dermatopathol 32: 614-617.
44. Zhang L, Yang N, Conejo-Garcia JR, Katsaros D, Mohamed-Hadley A, Fracchioli S, Schlienger K, Toll A, Levine B, Rubin SC, Coukos G (2003) Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin Cancer Res 9: 264-272.
45. Zhong C, Qu X, Tan M, Meng YG, Ferrara N (2009) Characterization and regulation of bv8 in human blood cells. Clin Cancer Res 15: 2675-2684.